Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease

Jie Zhu1, Yanjiang Wang, Jing Li

  • 1From the Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.

Neurology
|February 4, 2014
PubMed
Abstract

Insights

Intracranial arterial stenosis accelerates cognitive decline in individuals with mild cognitive impairment (MCI), increasing the risk of developing Alzheimer disease (AD) dementia.

Area of Science:

  • Neurology
  • Neuroscience
  • Medical Imaging

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal cognition and Alzheimer disease (AD).
  • Vascular factors, including intracranial arterial stenosis, may influence cognitive decline and dementia progression.

Purpose of the Study:

  • To investigate the association between intracranial arterial stenosis and the progression from MCI to AD dementia.
  • To evaluate the impact of stenosis severity on cognitive and functional decline in MCI patients.

Main Methods:

  • Longitudinal study of 423 MCI participants over 4 years with annual clinical and neuropsychological assessments.
  • CT angiography used to quantify intracranial arterial stenosis.
  • Mixed-effects regression and Cox proportional hazards models employed to analyze progression rates and dementia risk.

Main Results:

  • Participants with moderate or severe intracranial arterial stenosis showed faster cognitive and functional decline.
  • Intracranial arterial stenosis significantly elevated the risk of progressing to AD dementia.
  • These findings persisted after adjusting for demographic, vascular, and MRI lesion variables.

Conclusions:

  • Intracranial arterial stenosis is a significant risk factor for the progression from MCI to Alzheimer disease dementia.
  • Early identification and management of intracranial arterial stenosis may be crucial in preventing AD dementia.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19